B cells in allergic diseases: Bad or Better?

References

• Shaaban R, Zureik M, Soussan D, . Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008; 372:1049–1057.
   PubMed Web of Science ®Google Scholar
• Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001; 344:30–37.
   PubMed Web of Science ®Google Scholar
• Pearce N, Ait-Khaled N, Beasley R, . Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007; 62:758–766.
   PubMed Web of Science ®Google Scholar
• Gould HJ, Sutton BJ, Beavil AJ, . The biology of IGE and the basis of allergic disease. Annu Rev Immunol. 2003; 21:579–628.
   PubMed Web of Science ®Google Scholar
• Kisselgof AB, Oettgen HC. The expression of murine B cell CD23, in vivo, is regulated by its ligand, IgE. Int Immunol. 1998; 10:1377–1384.
   Google Scholar
• Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008; 8:205–217.
   PubMed Web of Science ®Google Scholar
• Acharya M, Borland G, Edkins AL, . CD23/FcepsilonRII: molecular multi-tasking. Clin Exp Immunol. 2010; 162:12–23.
   PubMed Web of Science ®Google Scholar
• Conrad DH, Ford JW, Sturgill JL, . CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep. 2007; 7:331–337.
   PubMed Web of Science ®Google Scholar
• Kijimoto-Ochiai S, Noguchi A. Two peptides from CD23, including the inverse RGD sequence and its related peptide, interact with the MHC class II molecule. Biochem Biophys Res Commun. 2000; 267:686–691.
   Google Scholar
• Getahun A, Hjelm F, Heyman B. IgE enhances antibody and T cell responses in vivo via CD23+B cells. J Immunol. 2005; 175:1473–1482.
   PubMed Web of Science ®Google Scholar
• Flores-Romo L, Johnson GD, Ghaderi AA, . Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses. Eur J Immunol. 1990; 20:2465–2469.
   Google Scholar
• Karagiannis SN, Warrack JK, Jennings KH, . Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology. 2001; 103:319–331.
   PubMedGoogle Scholar
• Mudde GC, Bheekha R, Bruijnzeel-Koomen CA. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol Today. 1995; 16:380–383.
   PubMedGoogle Scholar
• Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002; 2:773–786.
   PubMed Web of Science ®Google Scholar
• Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. 2002; 110:341–348.
   PubMed Web of Science ®Google Scholar
• Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010; 125:S73–S80.
   PubMed Web of Science ®Google Scholar
• Hamelmann E, Wahn U. Anti-IgE therapy. Clin Allergy Immunol. 2008; 21:415–427.
   Google Scholar
• Rodrigo GJ, Neffen H, Castro-Rodriguez JA. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest. 2011; 139:28–35.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176:705–710.
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008; 8:39–37.
   Google Scholar
• Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol. 2008; 20:332–338.
   PubMed Web of Science ®Google Scholar
• Mauri C, Ehrenstein MR. The ‘short’ history of regulatory B cells. Trends Immunol. 2008; 29:34–40.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Smith RN, . Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exper Med. 1997; 186:1749–1756.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Takedatsu H, . Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16:219–230.
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Sweenie CH, McGeachy MJ, . B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3:944–950.
   PubMed Web of Science ®Google Scholar
• Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev. 2011; 242:205–219.
   PubMed Web of Science ®Google Scholar
• Mizoguchi E, Mizoguchi A, Preffer FI, . Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000; 12:597–605.
   PubMed Web of Science ®Google Scholar
• Schmidt EG, Larsen HL, Kristensen NN, et al. B cells exposed to enterobacterial components suppress development of experimental colitis, Inflamm Bowel Dis 2011.
   Google Scholar
• Matsushita T, Yanaba K, Bouaziz JD, . Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008; 118:3420–3430.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Fujimoto M, Hasegawa M, . Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol. 2006; 168:812–821.
   PubMed Web of Science ®Google Scholar
• Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol. 2007; 179:7225–7232.
   PubMed Web of Science ®Google Scholar
• Lenert P, Brummel R, Field EH, . TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005; 25:29–40.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Ishiura N, Nakashima H, . Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol. 2010; 184:4801–4809.
   PubMed Web of Science ®Google Scholar
• Haas KM, Watanabe R, Matsushita T, . Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol. 2010; 184:4789–4800.
   PubMedGoogle Scholar
• Watanabe R, Fujimoto M, Ishiura N, . CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol. 2007; 171:560–570.
   PubMed Web of Science ®Google Scholar
• Nakashima H, Hamaguchi Y, Watanabe R, . CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol. 2010; 184:4637–4645.
   PubMedGoogle Scholar
• Rowe V, Banovic T, MacDonald KP, . Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood. 2006; 108:2485–2492.
   PubMed Web of Science ®Google Scholar
• Deng S, Moore DJ, Huang X, . Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol. 2007; 178:6028–6032.
   PubMed Web of Science ®Google Scholar
• Parsons RF, Vivek K, Rostami SY, . Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol. 2011; 186:614–620.
   Google Scholar
• Ding Q, Yeung M, Camirand G, . Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011; 121:3645–3656.
   PubMed Web of Science ®Google Scholar
• Singh A, Carson WF, Secor ERJr, . Regulatory role of B cells in a murine model of allergic airway disease. J Immunol. 2008; 180:7318–7326.
   PubMed Web of Science ®Google Scholar
• Miyazaki D, Kuo CH, Tominaga T, . Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2009; 50:1626–1635.
   PubMedGoogle Scholar
• Mangan NE, Fallon RE, Smith P, . Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol. 2004; 173:6346–6356.
   PubMed Web of Science ®Google Scholar
• Smits HH, Hammad H, van Nimwegen M, . Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J Allergy Clin Immunol. 2007; 120:932–940.
   Google Scholar
• Wilson MS, Taylor MD, O'Gorman MT, . Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol. 2010; 40:1682–1696.
   PubMed Web of Science ®Google Scholar
• Amu S, Saunders SP, Kronenberg M, . Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010; 125:1114–1124.
   PubMed Web of Science ®Google Scholar
• van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, Liu KY, Barr TA, Sparwasser T, Boon L, Ateba Ngoa U, Ngoune Feugap E, Adegnika AA, Kremsner PG, Yazdanbakhsh M, Smits HH. Schistosomes induce regulatory features in human and mouse CD1dhi B cells: inhibition of inflammation by IL-10 and enhanced regulatory T cells. PLoS One. 2012; 10:1.
   Google Scholar
• Evans JG, Chavez-Rueda KA, Eddaoudi A, . Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007; 178:7868–7878.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol. 2002; 32:848–857.
   PubMed Web of Science ®Google Scholar
• Lundy SK, Fox DA. Reduced Fas ligand-expressing splenic CD5+B lymphocytes in severe collagen-induced arthritis. Arthritis Res Ther. 2009; 11:R128.
   Google Scholar
• Matsushita T, Horikawa M, Iwata Y, . Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010; 185:2240–2252.
   PubMed Web of Science ®Google Scholar
• Wei B, Velazquez P, Turovskaya O, . Mesenteric B cells centrally inhibit CD4+T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA. 2005; 102:2010–2015.
   PubMed Web of Science ®Google Scholar
• Blair PA, Chavez-Rueda KA, Evans JG, . Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009; 182:3492–3502.
   PubMed Web of Science ®Google Scholar
• Carter NA, Vasconcellos R, Rosser EC, . Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011; 188:556–579.
   Google Scholar
• Sun JB, Flach CF, Czerkinsky C, . B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J Immunol. 2008; 181:8278–8287.
   PubMed Web of Science ®Google Scholar
• Tian J, Zekzer D, Hanssen L, . Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001; 167:1081–1089.
   PubMed Web of Science ®Google Scholar
• Minagawa R, Okano S, Tomita Y, . The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen. Transplantation. 2004; 78:799–806.
   Google Scholar
• Lundy SK, Berlin AA, Martens TF, . Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res. 2005; 54:514–521.
   PubMed Web of Science ®Google Scholar
• Klinker MW, Lundy SK. Multiple Mechanisms of Immune Suppression by B Lymphocytes. Mol Med. 2011.
   Google Scholar
• Lo-Man R. Regulatory B cells control dendritic cell functions. Immunotherapy. 2011; 3:19–20.
   PubMed Web of Science ®Google Scholar
• Blair PA, Norena LY, Flores-Borja F, . CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus Patients. Immunity. 2010; 32:129–140.
   PubMed Web of Science ®Google Scholar
• Mlejnek E, van der Vlugt LE, Ozir-Fazalalikhan A, . Impaired IL-10 expression by CD24hiCD27+ regulatory B cells in response to LPS in allergic asthmatic patients. Submitted. 2012.
   Google Scholar
• Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol. 2008; 64:187–199.
   PubMed Web of Science ®Google Scholar
• van den Biggelaar AH, van Ree R, Rodrigues LC, . Decreased atopy in children infected with Schistosoma haematobium: A role for parasite-induced interleukin-10. Lancet. 2000; 356:1723–1727.
   PubMed Web of Science ®Google Scholar
• Iwata Y, Matsushita T, Horikawa M, . Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011; 117:530–541.
   PubMed Web of Science ®Google Scholar
• Jackson JA, Friberg IM, Little S, . Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies?. Immunology. 2009; 126:18–27.
   PubMed Web of Science ®Google Scholar
• Maizels RM. Infections and allergy - helminths, hygiene and host immune regulation. Curr Opin Immunol. 2005; 17:656–661.
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh M, Rodrigues LC. Allergy and the hygiene hypothesis: the Th1/Th2 counterregulation can not provide an explanation. Wien Klin Wochenschr. 2001; 113:899–902.
   Google Scholar
• Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003; 3:733–744.
   PubMed Web of Science ®Google Scholar
• Jankovic D, Cheever AW, Kullberg MC, . CD4+T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exper Med. 1998; 187:619–629.
   PubMed Web of Science ®Google Scholar
• Gillan V, Lawrence RA, Devaney E. B cells play a regulatory role in mice infected with the L3 of Brugia pahangi. Int Immunol. 2005; 17:373–382.
   Google Scholar
• Palanivel V, Posey C, Horauf AM, . B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol. 1996; 84:168–177.
   Google Scholar
• Ronet C, Hauyon-La Torre Y, Revaz-Breton M, . Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol. 2010; 184:886–894.
   PubMed Web of Science ®Google Scholar
• von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010; 10:861–868.
   PubMed Web of Science ®Google Scholar
• Ege MJ, Mayer M, Normand AC, . Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011; 364:701–709.
   PubMed Web of Science ®Google Scholar
• Rook GA. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology. 2009; 126:3–11.
   PubMed Web of Science ®Google Scholar
• Dilillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci. 2010; 1183:3857.
   Google Scholar
• Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, . Regulatory B-cell induction by helminths: Implications for allergic disease. J Allergy Clin Immunol. 2011.
   Google Scholar
• Barr TA, Brown S, Ryan G, . TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007; 37:3040–3053.
   PubMed Web of Science ®Google Scholar
• Bouaziz JD, Calbo S, Maho-Vaillant M, . IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010; 40:268–291.
   Google Scholar
• Lampropoulou V, Hoehlig K, Roch T, . TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol. 2008; 180:4763–4773.
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Heine G, Zuberbier T, . Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy. 2009; 39:671–678.
   Google Scholar
• Velupillai P, Garcea RL, Benjamin TL. Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice. J Immunol. 2006; 176:1148–1153.
   Google Scholar
• Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+cells from schistosome-infected mice: a mechanism for regulation of CD4+T-cell subsets. Proc Natl Acad Sci USA. 1994; 91:18–22.
   Google Scholar
• Sayi A, Kohler E, Toller IM, . TLR-2-Activated B cells suppress Helicobacter-Induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol. 2011; 186:878–890.
   PubMed Web of Science ®Google Scholar
• Correale J, Farez M. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol. 2009; 183:5999–6012.
   PubMed Web of Science ®Google Scholar
• Neves P, Lampropoulou V, Calderon-Gomez E, . Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity. 2010; 33:777–790.
   PubMed Web of Science ®Google Scholar
• Jude BA, Pobezinskaya Y, Bishop J, . Subversion of the innate immune system by a retrovirus. Nat Immunol. 2003; 4:573–578.
   PubMed Web of Science ®Google Scholar
• Yang M, Sun L, Wang S, . Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol. 2010; 184:3321–3325.
   PubMed Web of Science ®Google Scholar
• Zhang X, Deriaud E, Jiao X, . Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exper Med. 2007; 204:1107–1118.
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003CD001186.
   Google Scholar
• Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006; 6:761–771.
   PubMed Web of Science ®Google Scholar
• Meiler F, Zumkehr J, Klunker S, . In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exper Med. 2008; 205:2887–2898.
   PubMed Web of Science ®Google Scholar
• Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006; 18:738–744.
   PubMed Web of Science ®Google Scholar
• Ling EM, Smith T, Nguyen XD, . Relation of CD4+CD25+regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004; 363:608–615.
   PubMed Web of Science ®Google Scholar
• Akdis M, Verhagen J, Taylor A, . Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004; 199:1567–1575.
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Passerini L, Gambineri E, . Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest. 2006; 116:1713–1722.
   PubMed Web of Science ®Google Scholar
• Hartl D, Koller B, Mehlhorn AT, . Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol. 2007; 119:1258–1266.
   PubMed Web of Science ®Google Scholar
• Xystrakis E, Urry Z, Hawrylowicz CM. Regulatory T cell therapy as individualized medicine for asthma and allergy. Curr Opin Allergy Clin Immunol. 2007; 7:535–541.
   Google Scholar
• Duddy M, Niino M, Adatia F, . Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007; 178:6092–6099.
   PubMed Web of Science ®Google Scholar
• Hauser SL, Waubant E, Arnold DL, . B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008; 358:676–688.
   PubMed Web of Science ®Google Scholar
• Ramgolam VS, Sha Y, Marcus KL, . B cells as a therapeutic target for IFN-beta in relapsing-remitting multiple sclerosis. J Immunol. 2011; 186:4518–4526.
   PubMed Web of Science ®Google Scholar
• Snir A, Kessel A, Haj T, . Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Clin Exp Rheumatol. 2011; 29:697–700.
   PubMed Web of Science ®Google Scholar
• Kala M, Rhodes SN, Piao WH, . B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol. 2010; 221:136–145.
   PubMed Web of Science ®Google Scholar
• Begum-Haque S, Christy M, Ochoa-Reparaz J, . Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate. J Neuroimmunol. 2011; 232:136–144.
   PubMed Web of Science ®Google Scholar
• Bodhankar S, Wang C, Vandenbark AA, . Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur J Immunol. 2011; 41:1165–1175.
   PubMed Web of Science ®Google Scholar